Overview

Angelyn assists in the preparation and prosecution of U.S. and foreign patent applications, specializing in the areas of chemistry, biochemistry, and biotechnology. In addition, she performs freedom to operate and patentability analyses, due diligence reviews, and provides general intellectual property counseling.

Angelyn brings several years of experience as a research scientist to her practice. She carried out her postdoctoral research at Harvard Medical School and received her Ph.D. from MIT, where she characterized various aspects of protein glycosylation through a combination of organic chemistry and biochemistry. Prior to graduate school, Angelyn was a research associate at Seattle Genetics, focused on developing antibody-drug conjugates for directed cancer therapy. She received a B.A. from Wellesley College, where she conducted undergraduate research on the synthesis of nucleoside analogs.

Angelyn is an author of several peer-reviewed scientific research articles published in Nature Chemical Biology, Biochemistry, and Bioorganic & Medicinal Chemistry.

Education and Prior Experience

  • Suffolk University Law School, Candidate for J.D. (expected 2019)
  • Massachusetts Institute of Technology, Ph.D., Organic Chemistry
  • Wellesley College, B.A., Chemistry and Political Science, with honors
  • Harvard Medical School, Postdoctoral Research
  • Seattle Genetics, Research Associate in Chemistry

Admissions, Memberships, and Acknowledgements

  • Registered to practice before the U.S. Patent and Trademark Office
  • Recipient, Ruth L. Kirschstein NIH Postdoctoral Fellowship
  • Recipient, Wyeth Scholarship at MIT
  • Recipient, Janette Houk Fellowship at MIT
  • Member, American Chemical Society
  • Member, American Society for Biochemistry and Molecular Biology

Event

Angelyn Larkin, Ph.D. was a panelist at MIT’s January IP Law Panel hosted by The Chemistry Department on January 26, 2016.

Federal Circuit Review

February Federal Circuit Review

Read this Federal Circuit Review

Press Release

L&A Expands Life Sciences Team

Read this Press Release